Evidence map›Paper›PMID 42170247›Full record

ArticleChina CDC weekly2026

Time to Antiretroviral Therapy Initiation After HIV Diagnosis in the Integrase Strand Transfer Inhibitor Era - Nanjing City, Jiangsu Province, China, 2021-2024.

Chenyu Ma, Jinjin Yang, Anni Liu, Zheng Qian, Ziyao Liu, You Ge, Yuanyuan Xu, Zhengping Zhu, Hongxia Wei, Zhihang Peng and 2 more

Abstract read
In one paragraph

Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chenyu MaSchool of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Jinjin YangSchool of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Anni LiuDepartment of Infectious Diseases, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing City, Jiangsu Province, China.
Zheng QianDepartment of Infectious Diseases, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing City, Jiangsu Province, China.
Ziyao LiuSchool of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
You GeDepartment of Infectious Diseases, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing City, Jiangsu Province, China.
Yuanyuan XuDepartment of AIDS/STD Control and Prevention, Nanjing Municipal Center for Disease Control and Prevention, Nanjing City, Jiangsu Province, China.
Zhengping ZhuDepartment of AIDS/STD Control and Prevention, Nanjing Municipal Center for Disease Control and Prevention, Nanjing City, Jiangsu Province, China.
Hongxia WeiDepartment of Infectious Diseases, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing City, Jiangsu Province, China.
Zhihang PengNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention & Chinese Academy of Preventive Medicine, Beijing, China.
Guoping YinSchool of Public Health, Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Zhiliang HuDepartment of Infectious Diseases, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing City, Jiangsu Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: In China, patients with human immunodeficiency virus are diagnosed at the CDC and then referred to hospitals for antiretroviral therapy (ART), but treatment delays persist. Previous studies have reported overall delay in time from diagnosis to ART initiation without identifying where delays occur. What is added by this report?: A Nanjing cohort study showed that hospital delays were almost eliminated with integrase strand transfer inhibitor (INSTI)-based regimens: 87.9% of patients initiated ART within 7 days of their first hospital visit. However, the main bottleneck remains CDC referral, as 49.8% of patients attended the hospital within 7 days of HIV confirmation. What are the implications for public health practice?: Shortening the CDC-to-hospital interval via stronger linkage and equitable INSTI access is critical for achieving rapid ART.

Indexed as

HIVIntegrase strand transfer inhibitorsLinkage to careRapid antiretroviral therapy initiation

Identifiers

PMID42170247
PMCPMC13187661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.